Explicit and implicit attachment and the outcomes of acceptance and commitment therapy and cognitive behavioral therapy for depression.

Acceptance and commitment therapy Attachment Cognitive behavioral therapy Depression IAT Implicit Predictors SC-IAT Treatment

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
07 04 2020
Historique:
received: 31 07 2019
accepted: 13 03 2020
entrez: 9 4 2020
pubmed: 9 4 2020
medline: 11 11 2020
Statut: epublish

Résumé

Attachment theory predicts that patients who are not securely attached may benefit less from psychological treatment. However, evidence on the predictive role of attachment in the effectiveness of treatment for depression is limited. Explicit attachment styles, levels of attachment anxiety and attachment avoidance, as well as implicit relational self-esteem and implicit relational anxiety were assessed in 67 patients with major depressive disorder (MDD) receiving Acceptance and Commitment Therapy (ACT) or Cognitive Behavioral Therapy (CBT). ANOVA and hierarchical regression analyses were performed to investigate the predictive power of explicit and implicit attachment measures on treatment outcome. Explicit attachment avoidance at pre-treatment significantly predicted reduction of depressive symptoms following treatment. Reductions in attachment anxiety and avoidance from pre- to post-treatment predicted better treatment outcomes. Neither one of the implicit measures, nor change in these measures from pre- tot post-treatment significantly predicted treatment outcome. Our findings show that attachment avoidance as well as reductions in avoidant and anxious attachment predict symptom reduction after psychological treatment for depression. Future research should use larger sample sizes to further examine the role of attachment orientation as moderator and mediator of treatment outcome. clinicaltrials.gov; NCT01517503.

Sections du résumé

BACKGROUND
Attachment theory predicts that patients who are not securely attached may benefit less from psychological treatment. However, evidence on the predictive role of attachment in the effectiveness of treatment for depression is limited.
METHODS
Explicit attachment styles, levels of attachment anxiety and attachment avoidance, as well as implicit relational self-esteem and implicit relational anxiety were assessed in 67 patients with major depressive disorder (MDD) receiving Acceptance and Commitment Therapy (ACT) or Cognitive Behavioral Therapy (CBT). ANOVA and hierarchical regression analyses were performed to investigate the predictive power of explicit and implicit attachment measures on treatment outcome.
RESULTS
Explicit attachment avoidance at pre-treatment significantly predicted reduction of depressive symptoms following treatment. Reductions in attachment anxiety and avoidance from pre- to post-treatment predicted better treatment outcomes. Neither one of the implicit measures, nor change in these measures from pre- tot post-treatment significantly predicted treatment outcome.
CONCLUSIONS
Our findings show that attachment avoidance as well as reductions in avoidant and anxious attachment predict symptom reduction after psychological treatment for depression. Future research should use larger sample sizes to further examine the role of attachment orientation as moderator and mediator of treatment outcome.
TRIAL REGISTRATION
clinicaltrials.gov; NCT01517503.

Identifiants

pubmed: 32264845
doi: 10.1186/s12888-020-02547-7
pii: 10.1186/s12888-020-02547-7
pmc: PMC7137238
doi:

Banques de données

ClinicalTrials.gov
['NCT01517503']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

155

Références

Value Health. 2012 May;15(3):449-57
pubmed: 22583455
Clin Psychol Rev. 2005 Nov;25(7):975-1002
pubmed: 15905008
Psychol Assess. 2011 Sep;23(3):615-25
pubmed: 21443364
J Abnorm Psychol. 2001 May;110(2):226-35
pubmed: 11358017
Psychother Res. 2019 Jan;29(1):78-85
pubmed: 28436756
J Couns Psychol. 2015 Oct;62(4):579-91
pubmed: 26376176
J Abnorm Child Psychol. 1999 Dec;27(6):439-45
pubmed: 10821625
J Pers Soc Psychol. 2006 Jul;91(1):16-32
pubmed: 16834477
Biol Psychiatry. 2006 Mar 15;59(6):493-501
pubmed: 16199008
J Pers Soc Psychol. 1998 Jun;74(6):1464-80
pubmed: 9654756
Biol Psychol. 2014 Apr;98:43-9
pubmed: 24239595
Am J Fam Ther. 2015 Jan 1;43(1):44-56
pubmed: 25642009
J Affect Disord. 2014 Apr;159:118-26
pubmed: 24679399
Asian J Psychiatr. 2014 Apr;8:104-5
pubmed: 24655638
J Pers Soc Psychol. 2009 Sep;97(3):533-48
pubmed: 19686006
J Consult Clin Psychol. 2006 Dec;74(6):1041-54
pubmed: 17154734
Clin Psychol Rev. 2010 Aug;30(6):691-709
pubmed: 20538393
Front Psychol. 2013 Dec 09;4:923
pubmed: 24367351
Psychol Rev. 2002 Jan;109(1):3-25
pubmed: 11863040
Psychother Psychosom. 2018;87(3):154-163
pubmed: 29566394
J Affect Disord. 2011 Feb;128(3):252-61
pubmed: 20674982
Pers Soc Psychol Bull. 2005 Oct;31(10):1369-85
pubmed: 16143669
Emotion. 2005 Jun;5(2):175-90
pubmed: 15982083
J Pers Soc Psychol. 2003 Aug;85(2):197-216
pubmed: 12916565
J Pers Soc Psychol. 2004 Dec;87(6):940-56
pubmed: 15598116
BMC Psychiatry. 2018 Nov 12;18(1):362
pubmed: 30419875
Bull Menninger Clin. 2016 Summer;80(3):255-80
pubmed: 27583812
Psychother Res. 2013;23(2):190-200
pubmed: 23387343
J Behav Ther Exp Psychiatry. 2002 Jun;33(2):115-33
pubmed: 12472175

Auteurs

Jacqueline G L A-Tjak (JGL)

Skils, Dr van Deenweg 98, 8025, BJ, Zwolle, the Netherlands.

Nexhmedin Morina (N)

Institute of Psychology, University of Münster, Fliednerstr. 21, 48149, Münster, Germany. morina@uni-muenster.de.

Wouter J Boendermaker (WJ)

Addiction, Development, and Psychopathology (ADAPT) Lab, Department of Psychology, University of Amsterdam, Nieuwe Achtergracht 129 B, 1018, WS, Amsterdam, The Netherlands.

Maurice Topper (M)

GGZ-Noord-Holland-Noord, Stationsplein 138, 1703, WC, Heerhugowaard, The Netherlands.

Paul M G Emmelkamp (PMG)

Department of Clinical Psychology, University of Amsterdam, Nieuwe Achtergracht 129 B, 1018, WS, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH